CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

GSK to invest $800M for new R&D, manufacturing hub in Pennsylvania 

Positive
AI Analysis

Summary

GSK plans to invest over $800 million to expand its R&D and manufacturing operations in Pennsylvania, with construction expected to begin in 2027 at its current site.

Importance:3/10
Sentiment:
0.50
expansionmanufacturingR&Dcapital_investmentPennsylvania
Related Companies

Read the original article

Published by Endpoints News on October 12, 2026 2:48 PM

Read Original